Kramer, J B <br/><br/>
Thromboxane A2 does not contribute to arrhythmogenesis during evolving canine myocardial infarction.  [electronic resource] 

 -  Journal of cardiovascular pharmacology   
 - 1069-76 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0160-2446 
<br/><br/><label>Standard No.: </label>10.1097/00005344-198511000-00009  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Action Potentials--drug effects<br/>Animals<br/>Arrhythmias, Cardiac--etiology<br/>Blood Pressure--drug effects<br/>Dogs<br/>Electric Stimulation<br/>Heart Conduction System--drug effects<br/>Heart Rate--drug effects<br/>In Vitro Techniques<br/>Myocardial Infarction--complications<br/>Thromboxane A2--pharmacology